Publications

Development and clinical performance of high throughput loop-mediated isothermal amplification for detection of malaria.

Perera, RS; Ding, XC; Tully, F; Oliver, J; Bright, N; Bell, D; CHIODINI, PL; Gonzalez, IJ; Polley, SD;

2017

PloS one, (2017).12 2 10.1371/journal.pone.0171126.

pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.

SUTHERLAND, CJ; LANSDELL, P; Sanders, M; Muwanguzi, J; VAN SCHALKWYK, DA; KAUR, H; NOLDER, D; TUCKER, J; Bennett, HM; Otto, TD; Berriman, M; Patel, TA; Lynn, R; Gkrania-Klotsas, E; CHIODINI, PL;

2017

Antimicrobial agents and chemotherapy, (2017).61 3 10.1128/AAC.02382-16.

Working towards consensus on methods used to elicit participant-reported safety data in uncomplicated malaria clinical drug studies: a Delphi technique study.

Mandimika, N; Barnes, KI; CHANDLER, CI R; Pace, C; Allen, EN;

2017

Malaria journal, (2017).16 1 10.1186/s12936-017-1699-x.

THE REAL McCOIL: A method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites.

Chang, H-H; Worby, CJ; Yeka, A; Nankabirwa, J; Kamya, MR; STAEDKE, SG; Dorsey, G; Murphy, M; Neafsey, DE; Jeffreys, AE; Hubbart, C; Rockett, KA; Amato, R; Kwiatkowski, DP; Buckee, CO; Greenhouse, B;

2017

PLoS computational biology, (2017).13 1 10.1371/journal.pcbi.1005348.

Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination.

BIGGS, J; Raman, J; COOK, J; Hlongwana, K; DRAKELEY, C; Morris, N; Serocharan, I; Agubuzo, E; Kruger, P; Mabuza, A; Zitha, A; Machaba, E; Coetzee, M; KLEINSCHMIDT, I;

2017

Malaria journal, (2017).16 1 10.1186/s12936-017-1701-7.

Culture adaptation of malaria parasites selects for convergent loss-of-function mutants.

CLAESSENS, A; Affara, M; ASSEFA, SA; Kwiatkowski, DP; CONWAY, DJ;

2017

Scientific reports, (2017).7 1 10.1038/srep41303.

Malaria and Economic Evaluation Methods: Challenges and Opportunities.

DRAKE, TL; Lubell, Y;

2017

Applied health economics and health policy, (2017).15 3 10.1007/s40258-016-0304-8.

Type I Interferon in Malaria: A Balancing Act.

MOONEY, JP; WASSMER, SC; HAFALLA, JC;

2017

Trends in parasitology, (2017).33 4 10.1016/j.pt.2016.12.010.

Introducing rapid tests for malaria into the retail sector: what are the unintended consequences?.

HUTCHINSON, E; HUTCHISON, C; LAL, S; HANSEN, K; Kayendeke, M; Nabirye, C; Magnussen, P; CLARKE, SE; Mbonye, A; CHANDLER, CI R;

2017

BMJ global health, (2017).2 1 10.1136/bmjgh-2016-000067.

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.

Clarke, GM; Rockett, K; Kivinen, K; Hubbart, C; Jeffreys, AE; Rowlands, K; Jallow, M; CONWAY, DJ; BOJANG, KA; Pinder, M; Usen, S; Sisay-Joof, F; Sirugo, G; Toure, O; Thera, MA; Konate, S; Sissoko, S; Niangaly, A; Poudiougou, B; Mangano, VD; Bougouma, EC; Sirima, SB; Modiano, D; Amenga-Etego, LN; Ghansah, A; ... MalariaGEN Consortium,

2017

eLife, (2017).6, 10.7554/eLife.15085.